Please wait, loading...
CBD products linked to a submitted, rather than validated, novel food application can now remain on the UK market after 31 March, according to new guidance from regulator the Food Standards Agency.
Europe’s hemp industry hit a milestone last week when the European Union’s top court liberated CBD from the jurisdiction of an international drug treaty, declaring that hemp-derived cannabidiol is not a narcotic.
In this video Stephen Oliver, Co-Founder of The Canna Consultants, explains the opportunities and barriers to investment in the European Space during the Med-Cann Virtual Summit. He offers some great advice, addressing the need to think alternatively and adapt to new situations.
Stephen Oliver former Customs Investigator and Matt Lawson Barrister are both experts in the cannabinoid industry, they are the founders of The Canna Consultants and will be speaking at the event on both days.
Stephen Oliver and Matt Lawson are both experts in the cannabinoid industry, they are the founders of The Canna Consultants and will be speaking at the Cannabis Investment Summit World (CISW) which takes place 11-13 of November 2020.
The race for earliest submission of a Novel Food Dossier is a false one. This is especially the case when submissions made thus far, so we understand, lack the appropriate scientific data in respect of end products for which Authorisation is being contended and, in some cases, lack any scientific data in respect of the subject of the application at all.
On 14th May 2020 the Advocate General (Tanchev) of the Court of Justice of the European Union (CJEU) delivered their Opinion on the above question. The result is both a “Yes” and a “No”: National restrictions by Member States are possible, but such restrictions as are sought to be enforced must be (a) justified and (b) no more than necessary in order to achieve the justified aim.
Another snippet from the Global Cannabis Town Hall. Discussing collegiate Novel Food Applications and the potential issues with proprietary data. Answering questions on the future of the CBD Industry and the impact of Novel Foods post Covid-19. Watch the video here with Steve Oliver answering the question during the First Global Cannabinoid Webinar.
During the Global Cannabis Town Hall we were asked whether we thought other EU states would follow the FSA's lead and grant their own transition period 'passes' for Novel Food applicants. Watch the video here with Steve Oliver answering the question during the First Global Cannabinoid Webinar.
Novel Foods applications, submissions and the challenge with toxicology tests. Watch the video here with Steve Oliver answering industry questions during the First Global Cannabinoid Webinar.